Published in Ryoikibetsu Shokogun Shirizu on January 01, 2002
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72
Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest (2003) 1.65
The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE). J Headache Pain (2005) 1.52
Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. J Pediatr Gastroenterol Nutr (2012) 1.47
Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia (2013) 1.41
Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA. Intern Med (2003) 1.40
Evidence against strong correlation between chest symptoms and ischemic coronary changes after subcutaneous sumatriptan injection. Intern Med (2002) 1.40
The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res (2010) 1.24
Slowly progressive spread of the stroke-like lesions in MELAS. Neurology (2003) 1.21
Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern Med (2009) 1.18
[Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology]. Brain Nerve (2008) 1.09
Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res (2005) 1.04
Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS -- implication of neurovascular cellular mechanism. J Neurol Sci (2007) 0.99
Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations. J Neurol (2012) 0.99
Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci (2008) 0.92
Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache (2003) 0.91
Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache (2008) 0.90
The efficacy of goshuyuto, a typical Kampo (Japanese herbal medicine) formula, in preventing episodes of headache. Curr Med Res Opin (2006) 0.90
LRRK2 I2020T mutation is associated with tau pathology. Parkinsonism Relat Disord (2012) 0.86
Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry (2011) 0.86
Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice. J Bone Miner Res (2011) 0.84
Osteopontin is dispensable for protection against high load systemic fungal infection. Int Immunopharmacol (2008) 0.82
[Neurosarcoidosis]. Nihon Rinsho (2002) 0.82
[Update on anti-NMDA receptor encephalitis]. Brain Nerve (2010) 0.82
Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol (2007) 0.81
Development and testing of the Japanese version of the migraine-specific quality of life instrument. Qual Life Res (2004) 0.78
Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. Ther Apher Dial (2004) 0.78
FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models. J Antibiot (Tokyo) (2003) 0.78
Response to sumatriptan in headache of MELAS syndrome. Neurology (2003) 0.78
[Examination of Staphylococcus aureus survival and growth during cheese-making process]. Shokuhin Eiseigaku Zasshi (2008) 0.77
Botulinum toxin type A for migraine prophylaxis in the Japanese population: an open-label prospective trial. Intern Med (2007) 0.77
Prevention of the cryptic epitope SLAYGLR within osteopontin does not influence susceptibility to Candida albicans infection. Antimicrob Agents Chemother (2005) 0.76
Natural IgG antibody with anti-β-galactosyl specificity suppressed hepatoma cell invasion in culture. Cytotechnology (2012) 0.75
Headache and spontaneous vertebral artery dissection. Intern Med (2002) 0.75
[Prophylactic treatment with botulinum toxin type A]. Nihon Rinsho (2005) 0.75
Vertical gaze palsy associated with bilateral ptosis following right putaminal hemorrhage. J Stroke Cerebrovasc Dis (2007) 0.75
Development of a comprehensive medical recorder on a cellphone. Comput Methods Programs Biomed (2009) 0.75
Multi-center randomized control trial of etizolam plus NSAID combination for tension-type headache. Intern Med (2007) 0.75
[Clinical guideline review: Headache]. Nihon Naika Gakkai Zasshi (2002) 0.75
[Recent progress in therapy for migraine headache]. Nihon Naika Gakkai Zasshi (2004) 0.75
[Guideline for the practice of headache]. Rinsho Shinkeigaku (2006) 0.75